Health Economics & Outcomes Research (HEOR)

June 2026 Medical/Commercial Pulse Check

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

HealthEconomics.com 2026 Pulse Check – March

When the Evidence Fails the Drug: Is the Role of Study Design Being Overlooked During Discovery?

Navigating Shifts in Pharmaceutical Policy: Impacts and Future Outlook

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Network meta-analysis and its role in evidence-based decision-making

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Market Access - Transforming BioTech Commercial Decisions?

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Pharma can target ultra-rare conditions ‚Äî the next step is financing them

Transforming Healthcare Using Big Data and Remote Monitoring

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Minimizing the Impact of Cross-Cultural Differences in COA Translations

Synthesise RWE and AI. Transform patient-driven healthcare

Endpoints at #DIA23

Certified Corporate Wellness Specialist(CCWS): Is It For Me?

L7|LIVE SF - Tuesday, June 13th, 2023

Connected communities: Advancing population health through data and emerging technology

The reimagined hospital: How health systems are keeping up with new tech

Clinical Trial Innovation: How Healthcare Technology is Evolving

Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change

Advancing identity data management for digital engagement: How leading organizations are doing it

How Digital Health Can Empower Cancer Patients

Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model

Closing the gaps of getting data to make decisions

Medicare Part D: Price Negotiation Panel Discussion

From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Finding Value in Linking Real-World Data with Social Determinants of Health

Unlock the Power of Data Review & Collaboration: Maximizing Trial Success

Ushering in the new era of payvider integration

How to Supercharge Real World Evidence Generation in Phase IV Trials

Partnering with NHS in a crisis: The role for industry

HTA Implementation in the MEA Region - an Overview from WHO and Country Updates

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

FDA Patient-Focused Drug Development (PFDD) Guidance

Creating Digital Biomarkers with Real-World and Existing Data by Xtalks

Beyond the payment variance report: How to resolve common, costly underpayment issues

Webcast: Strategies to Simplify Insurance Discovery

Different HTA Perspectives on Reliably Estimating Treatment Effects

Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems

Measuring the intangible- what is the true value of a "patient centric" initiative

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

Streamlining Health Technology Assessments by Automating Literature Reviews

Champion a seamless end-to-end insight generation process

Evidence Matters 2022

Achieving Consensus When Everyone is an Expert, but No One Agrees

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

Making HEOR More Accessible to Patients

Fit for Local Context? Establishing or Improving Deliberative Processes for HTA

An Introduction to Infectious Disease Modeling

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

Cell & Gene Day 2022 | Virtual Event | August 24th

Confronting care inequities in hospital medicine - August 18th, 2022

Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT

Pain R&D: Plenty of pain to go around, but who's making gains?

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient

Understanding Health Care Decision Maker Preferences for Optimized Engagement

Data Integrity in Decentralized Clinical Trials (DCTs)

How Cerner Enviza Uses Clinical Data to Drive RWE Decisions

Optimizing Real-World Evidence for Maternal and Neonatal Outcomes

How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies

Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making

Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved Monitoring & Supportive Care

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

Value-Based Agreements - Are We Going to See More or Less of Them?

Selecting Rapid Review Methods for Health Technology Assessment

Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible

Predicting Payer Uptake with Precision

Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy

It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability

Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality

Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap

Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO

INsights & OUTcomes with Dalfoni Banerjee

tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies

INsights & OUTcomes with Renée Arnold

Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner

INsights & OUTcomes with Matt McLoughlin

INsights & OUTcomes with Catherine Bacon

INsights & OUTcomes with Vernon Schabert

INsights & OUTcomes with Rosa Willock

INsights & OUTcomes with Chris O'Neill

Between Two Scientists: Care During Pregnancy - How RWD Can Help Balance the Needs of Mom and Baby

How AI-Powered Phenotyping Enhances the Patient Journey for Life Science Applications

Podcast Q&A: Clinical Outcomes Assessments and Training

Podcast Q&A: Patient-Centered Real-World Evidence in Rare Diseases

Podcast Q&A: Real-World Evidence Generation with Disease Registries

Podcast Q&A: Clinical Outcome Assessment (COA) Translations

#ExpertAnswers: Christopher Perry and Homira Osman on Integrating Patients, Clinical, and Advocacy Partners with Preclinical Research Labs

Total System Value - A DYNAMIC APPROACH TO VALUE DEMONSTRATION

How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D

Industry Insights with Sino Biological: Cytokines - Catalysts of the Regenerative Revolution

Podcast Q&A: The Benefits of Linking SDOH with Other Real-World Data

Podcast Q&A: Literature Reviews and Global Value Dossiers

Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System

Podcast Q&A: Improving Health Literacy

Getting Real About Real-World Data